The Role of Route of Entry by Bacterial Antigens on Colonic T Cell Responses
细菌抗原进入途径对结肠 T 细胞反应的作用
基本信息
- 批准号:10396536
- 负责人:
- 金额:$ 55.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-23 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AntibioticsAntigen PresentationAntigensAutomobile DrivingB-LymphocytesBacteriaBacterial AntigensBiological AssayCellsChronicCoculture TechniquesColonDataDendritic CellsDevelopmentDiseaseEnvironmentFOXP3 geneFlow CytometryGoblet CellsHealth PromotionHelicobacterHomeostasisImageImmuneImmune responseImmune systemImmunityIn VitroInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseIntestinesInvestigationKnowledgeLiteratureLocationManuscriptsMediatingMetagenomicsMucosal Immune SystemMucous MembraneMusOutcomePathogenesisPathologyPeripheralPhenotypePlayPopulationProcessRegulatory T-LymphocyteRoleRouteT cell responseT-Cell DevelopmentT-LymphocyteT-cell receptor repertoireTimeWorkantigen-specific T cellsbasecommensal bacteriadysbiosiseffector T cellgenetic approachgut bacteriagut dysbiosisgut microbiotaimaging approachin vivomicrobialpathobiontpathogenpathogenic bacteriapreventresponsetranscriptome sequencing
项目摘要
Project Summary
Effector T cell responses to pathogenic bacteria are crucial for protection from pathogens, but when directed
toward non-pathogens, may underlie inappropriate responses driving disorders such as inflammatory bowel
disease (IBD). Conversely, Foxp3+ regulatory T cell (Treg) responses to commensals enforce tolerance to
prevent immune-mediated pathology such as IBD. The relative priority and context of gut bacterial interaction
with the immune system remain significant gaps in our understanding. We observed that dysbiosis induces the
formation of colonic goblet cell associated antigen passages (GAPs), providing an alternative route by which
the immune system encounters gut resident bacteria. Further, we observed that gut resident bacteria taxa
generally considered as tolerance-promoting can induce effector responses when encountered via colonic
GAPs. Alternatively, we have found that antigen-specific peripheral (pTregs) largely recognize mucosal
associated (MA) murine Helicobacter spp in vitro and in vivo, and that encounter of Helicobacter spp occurs
continuously and is independent of GAPs. These data indicate that bacteria believed to be pathobionts can be
potent inducers of pTregs during homeostasis, and in contrast, taxa believed to be tolerance inducing,
Clostridia, are largely not encountered by the immune system in the steady state, but are encountered via
colonic GAPs resulting in effector T cell responses. We hypothesize that the location and route of encounter of
gut bacteria are important determinants of the outcome of immune responses and that the MA bacteria can
play an important role in controlling the interactions and responses to gut resident bacteria encountered via
colonic GAPs. In this proposal we will evaluate this hypothesis by: 1) defining the commensal antigens
delivered via mucosal association (MA) and GAPs 2) defining the dendritic cell (DC) subsets involved in
acquisition and presentation of mucosal associated and GAP delivered commensal antigens and 3) defining
the effects of Helicobacter on the mucosal immune system and responses to GAP delivered antigens. Studies
outlined in this proposal will fill the gaps in our understanding by identifying how specific bacterial taxa are
encountered by the immune system and the subsequent immune responses. This knowledge can be leveraged
to guide manipulations of the gut microbiota and the immune system to ‘reset’ chronic inflammatory responses
and return to homeostasis.
项目摘要
效应T细胞对病原菌的反应对于保护免受病原体的侵害至关重要,但当
对非病原体,可能是不适当的反应驱动疾病,如炎症性肠病,
疾病(IBD)。相反,Foxp3+调节性T细胞(Treg)对唾液酸的应答增强了对唾液酸的耐受性。
预防免疫介导的病理,如IBD。肠道细菌相互作用的相对优先级和背景
与免疫系统之间的关系在我们的理解中仍然存在重大差距。我们观察到,生态失调会导致
结肠杯状细胞相关抗原通道(GAP)的形成,提供了一种替代途径,
免疫系统遇到肠道常驻细菌。此外,我们观察到肠道常驻细菌类群
通常被认为是促进耐受性的,当通过结肠途径遇到时,
差距。另外,我们发现抗原特异性外周血淋巴细胞(pT淋巴细胞)在很大程度上识别粘膜上皮细胞。
相关(MA)小鼠螺杆菌属在体外和体内,并遇到螺杆菌属发生
它是连续的,并且独立于GAP。这些数据表明,被认为是致病菌的细菌可以被
在体内平衡过程中pT3的有效诱导剂,相反,认为是耐受诱导的分类群,
梭菌在稳定状态下基本上不被免疫系统遇到,而是通过免疫系统遇到。
结肠GAP导致效应T细胞应答。我们假设,在一次袭击中,
肠道细菌是免疫应答结果的重要决定因素,
在控制与肠道常驻细菌的相互作用和反应方面发挥重要作用,
结肠间隙。在这个建议中,我们将通过以下步骤来评估这一假设:1)定义细胞抗原
通过粘膜联合(MA)和GAP 2)递送,定义了参与的树突状细胞(DC)亚群,
获得和呈递粘膜相关的和GAP递送的粘膜抗原,和3)确定
幽门螺杆菌对粘膜免疫系统的影响和对GAP递送抗原的应答。研究
本提案中概述的方法将通过确定特定的细菌分类群是如何
免疫系统和随后的免疫反应。这些知识可以用来
引导肠道微生物群和免疫系统的操作,以“重置”慢性炎症反应
并恢复体内平衡
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulatory T Cells Developing Peri-Weaning Are Continually Required to Restrain Th2 Systemic Responses Later in Life.
- DOI:10.3389/fimmu.2020.603059
- 发表时间:2020
- 期刊:
- 影响因子:7.3
- 作者:Knoop KA;McDonald KG;Hsieh CS;Tarr PI;Newberry RD
- 通讯作者:Newberry RD
Airway Microbiota-Host Interactions Regulate Secretory Leukocyte Protease Inhibitor Levels and Influence Allergic Airway Inflammation.
- DOI:10.1016/j.celrep.2020.108331
- 发表时间:2020-11-03
- 期刊:
- 影响因子:8.8
- 作者:Jaeger N;McDonough RT;Rosen AL;Hernandez-Leyva A;Wilson NG;Lint MA;Russler-Germain EV;Chai JN;Bacharier LB;Hsieh CS;Kau AL
- 通讯作者:Kau AL
Gut Helicobacter presentation by multiple dendritic cell subsets enables context-specific regulatory T cell generation.
- DOI:10.7554/elife.54792
- 发表时间:2021-02-03
- 期刊:
- 影响因子:7.7
- 作者:Russler-Germain EV;Yi J;Young S;Nutsch K;Wong HS;Ai TL;Chai JN;Durai V;Kaplan DH;Germain RN;Murphy KM;Hsieh CS
- 通讯作者:Hsieh CS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHYI S HSIEH其他文献
CHYI S HSIEH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHYI S HSIEH', 18)}}的其他基金
CAR-T cell treatment of CNS Autoimmunity
CAR-T细胞治疗中枢神经系统自身免疫
- 批准号:
10641913 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:
CAR-T cell treatment of CNS Autoimmunity
CAR-T细胞治疗中枢神经系统自身免疫
- 批准号:
10539779 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:
B cell-targeted CAR-T treatment of CNS Autoimmunity
B细胞靶向CAR-T治疗中枢神经系统自身免疫
- 批准号:
10514950 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:
Immune interactions with commensal microbes in early life
生命早期与共生微生物的免疫相互作用
- 批准号:
10567936 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:
B cell-targeted CAR-T treatment of CNS Autoimmunity
B细胞靶向CAR-T治疗中枢神经系统自身免疫
- 批准号:
10677698 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:
The Role of Route of Entry by Bacterial Antigens on Colonic T Cell Responses
细菌抗原进入途径对结肠 T 细胞反应的作用
- 批准号:
9912712 - 财政年份:2018
- 资助金额:
$ 55.27万 - 项目类别:
ROLE OF STRESS IN GUT IMMUNE INTERACTIONS WITH COMMENSAL BACTERIA
压力在肠道免疫与共生细菌相互作用中的作用
- 批准号:
10204715 - 财政年份:2018
- 资助金额:
$ 55.27万 - 项目类别:
相似海外基金
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:
10836880 - 财政年份:2023
- 资助金额:
$ 55.27万 - 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
- 批准号:
10734324 - 财政年份:2023
- 资助金额:
$ 55.27万 - 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 55.27万 - 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
- 批准号:
23K04971 - 财政年份:2023
- 资助金额:
$ 55.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
- 批准号:
2885451 - 财政年份:2023
- 资助金额:
$ 55.27万 - 项目类别:
Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
- 批准号:
10385926 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
- 批准号:
10509043 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10704008 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
- 批准号:
10818273 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10349397 - 财政年份:2022
- 资助金额:
$ 55.27万 - 项目类别:














{{item.name}}会员




